Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat
Spicy foods may increase digestive discomfort
Attach the needle if using separate components
Retatrutide represents a breakthrough in obesity pharmacotherapy because it does something no other weight loss medication accomplishes: it burns calories from two directions simultaneously
However, it is crucial to be patient and follow your doctors instructions to achieve the best results
Third, assess if your current dose remains optimal or if you need an increase